When evaluating sources to complete a Follistatin buy for scientific investigation, laboratory researchers require absolute chemical identity, verifiable purity, and strict endotoxin limits. PX1 Research delivers USA-manufactured, research-grade peptides supported by comprehensive third-party analytical testing for uncompromised experimental reproducibility.
When evaluating sources to complete a Follistatin buy for scientific investigation, laboratory researchers require absolute chemical identity, verifiable purity, and strict endotoxin limits. PX1 Research delivers USA-manufactured, research-grade peptides supported by comprehensive third-party analytical testing for uncompromised experimental reproducibility.
When evaluating options for a Follistatin buy for laboratory research, investigators must prioritize verified chemical purity, lot-specific COAs, and rigorous endotoxin control. PX1 Research provides USA-manufactured Follistatin characterized by reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry to ensure ≥98% purity, facilitating reliable results in preclinical signaling and myostatin inhibition assays.
Acquiring high-purity biomolecules is fundamental to maintaining integrity across complex cell culture protocols and animal models. Unverified peptides often contain truncations, trifluoroacetate (TFA) salt residues, or bacterial endotoxins that can corrupt cellular assays and induce non-specific inflammatory signaling. By choosing an analytical-first supplier, laboratories eliminate confounding variables before initiating preclinical protocols.
Follistatin is an autocrine glycoprotein expressed in nearly all vascularized tissues, functioning primarily as a potent antagonist to select members of the Transforming Growth Factor-beta (TGF-β) superfamily. In laboratory models, Follistatin binds directly to activins—specifically Activin A and Activin B—as well as Myostatin (Growth Differentiation Factor 8, or GDF-8). By forming an irreversible, high-affinity complex with these ligands, Follistatin prevents them from engaging their cognate type II activin receptors (ActRIIA and ActRIIB).
Preclinical studies suggest that suppressing ActRIIB receptor binding inhibits downstream Smad2/3 transcription factor phosphorylation. In skeletal muscle cell cultures and murine models, this inhibition blocks the expression of muscle-atrophy-related ubiquitin ligases, such as Atrogin-1 and MuRF1. Researchers investigating muscle hypertrophy, fibrosis, and metabolic homeostasis rely on high-purity Follistatin variants to map these intracellular cascades without background interference from impure recombinant proteins.
Detailed mapping of these pathways is available through our dedicated research library, where investigators can explore comparative biochemical analyses of TGF-β family modulators.
In vitro data indicate that applying recombinant Follistatin to C2C12 myoblast cultures promotes myotube differentiation, increases fusion index, and upregulates heavy-chain myosin expression. These findings have made Follistatin a primary tool for evaluating skeletal muscle regeneration after mechanical or ischemic injury. Because Myostatin functions as a negative regulator of muscle mass, neutralizing its binding capacity permits uninhibited myoblast proliferation in controlled laboratory environments.
Beyond myogenesis, animal study models involving transgenic or protein-infused rodents demonstrate that Follistatin plays a key role in mitigating tissue fibrosis. By sequestering Activin A, Follistatin decreases hepatic and renal extracellular matrix deposition in preclinical models of chronic organ damage. Investigators conducting research into connective tissue remodeling frequently pair Follistatin with related growth factors to observe synergistic extracellular matrix regulation.
To view specifications for specific recombinant variants, researchers can explore our active Follistatin-344 product listing for detailed lot data.
When designing pathways assays targeting tissue growth, cellular differentiation, or metabolic flux, researchers often compare Follistatin against other specialized compounds in the growth factor and myostatin-inhibition pathways. Understanding the distinct receptor affinities and biochemical actions of each molecule is crucial for proper experimental design.
In comparative preclinical protocols, investigators frequently test Follistatin-344 alongside direct signaling agonists such as IGF-1 LR3 and alternative signaling modulators found within the broader class of myostatin inhibitors. While Follistatin operates primarily by neutralizing ligand-receptor interactions upstream (sequestering Myostatin and Activin A), IGF-1 LR3 stimulates the Akt/mTOR phosphorylation cascade via direct receptor tyrosine kinase activation. Conversely, soluble extracellular decoy receptors like ACE-031 target overlapping ligands with differing binding kinetics. Evaluating these complementary mechanisms allows researchers to decipher multi-pathway cross-talk in cell culture and preclinical tissue models.
The integrity of preclinical data depends entirely on the analytical standards of the peptide vendor. PX1 Research adheres to stringent quality control guidelines, subjecting every batch of synthesized peptides to rigorous testing in an ISO 17025 accredited laboratory setting. We utilize Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity standards exceeding 98%, ensuring that no secondary peptide fragments or synthetic side-products contaminate your experimental setup.
In addition to RP-HPLC, Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF analysis is performed on every lot to confirm precise molecular weight and sequence accuracy. Crucially, because recombinant peptides are synthesized or expressed in specialized biological systems, endotoxin contamination poses a critical threat to cell viability. PX1 Research executes Chromogenic LAL (Limulus Amebocyte Lysate) assays to confirm endotoxin levels remain below 0.1 EU/mg, providing a safe medium for delicate in vitro assays and animal study models.
Explore our full catalog of tested analytical standards by browsing all research peptides currently available for lab procurement.
Recombinant Follistatin is supplied as a lyophilized (freeze-dried) powder under vacuum to maximize long-term stability. Upon receipt, unopened vials should be stored in a commercial freezer at -20°C or -80°C, protected from light and moisture. Lyophilized peptides preserved under these conditions maintain structural stability for extended periods without significant degradation.
For reconstitution in a laboratory setting, vials should be allowed to acclimate to room temperature before opening to prevent condensation formation inside the container. Reconstitution should be performed using sterile Bacteriostatic Water, Sterile Water for Injection, or specialized phosphate-buffered saline (PBS, pH 7.4), depending on downstream application requirements. Gentle swirling is recommended to dissolve the lyophilized cake; vigorous vortexing should be avoided as mechanical shear stress can denature complex peptide secondary structures. Once reconstituted, liquid aliquots should be stored at 2°C to 8°C for short-term experimentation or stored frozen at -80°C in single-use aliquots to avoid repeated freeze-thaw cycles.
A reliable Certificate of Analysis (COA) is more than a standard PDF document—it is verifiable proof of compound identity and purity. When executing a Follistatin buy, researchers must inspect the COA for lot-matched raw analytical data rather than template graphics. PX1 Research publishes true, lot-specific HPLC chromatograms and mass spectra for every order, allowing researchers to independently inspect peak integration areas and mass-to-charge ratios.
Batch traceability ensures that every vial dispatched from our California and Arizona logistics facilities can be tracked directly back to its synthesis run, purification column logs, and sterile vial filling environment. Maintaining this chain of custody guarantees that institutional laboratories receive consistent, reproducible material order after order. For comprehensive information on reading raw analytical output, review our technical guide on peptide quality standards.
PX1 Research supports university research departments, biotechnology firms, and contract research organizations (CROs) with scalable supply solutions. Institutional buyers requiring bulk quantities or dedicated lot reservations for long-term longitudinal studies can utilize our established procurement channels to streamline supply chain management.
All orders are processed from our USA facilities with same-day shipping available Monday through Friday. Whether acquiring single vials for preliminary pilot studies or establishing high-volume custom contracts, researchers benefit from uniform lot quality and dedicated technical support. Qualified institutional representatives are encouraged to explore our wholesale account portal to discuss batch reservations, bulk pricing tiers, and custom packaging protocols.
What is the primary biological function of Follistatin in research models?
Follistatin acts primarily as an autocrine binding protein that neutralizes TGF-β superfamily ligands, specifically Myostatin (GDF-8) and Activin A. In preclinical research models, it prevents these ligands from binding to activin type II receptors, thereby modulating cellular differentiation, myogenesis, and extracellular matrix deposition.
How is Follistatin purity verified before dispatch?
Every lot of Follistatin supplied by PX1 Research undergoes rigorous testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination (≥98%) and Mass Spectrometry (MS) for molecular mass verification. Endotoxin levels are measured via chromogenic LAL assays.
What is the structural difference between Follistatin-344 and other isoforms?
Follistatin-344 is a precursor protein that undergoes post-translational splicing to yield isoform variations such as Follistatin-315 and Follistatin-288. In laboratory research, Follistatin-344 cDNA or recombinant peptide variants are widely utilized due to their tissue-binding properties and systemic stability in animal models.
What are the endotoxin limits for PX1 Research Follistatin?
PX1 Research mandates that endotoxin content in research-grade Follistatin remains strictly below 0.1 EU/mg (Endotoxin Units per milligram). Low endotoxin levels are vital to prevent activation of Toll-like receptor pathways in cell culture and preclinical models.
How should lyophilized Follistatin be stored upon arrival at the lab?
Lyophilized Follistatin should be stored at -20°C or -80°C upon receipt. Stored at sub-zero temperatures away from moisture and direct light, the freeze-dried powder remains stable for long-term laboratory storage.
Can Follistatin be reconstituted in standard phosphate-buffered saline (PBS)?
Yes, lyophilized Follistatin can be reconstituted in sterile, cell-culture-grade phosphate-buffered saline (pH 7.4) or sterile bacteriostatic water depending on the target assay requirements. Gentle inversion is recommended over aggressive mechanical agitation.
How does Follistatin differ from IGF-1 LR3 in cell signaling studies?
Follistatin operates through ligand sequestration (blocking negative growth regulators like Myostatin and Activin), whereas IGF-1 LR3 is a direct receptor agonist that activates the insulin-like growth factor receptor and downstream Akt/mTOR cascades. They target distinct arms of cellular protein synthesis pathways.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and dispatched directly from our optimized logistics facilities located in California and Arizona, offering same-day shipping on standard business days.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.